Adrien Chetioui presents research on drones and opioid risks
Esteemed CTM-E member and researcher, Adrien Chetioui of the Service Départemental d’Incendie et de Secours du Gard (SDIS30, France), recently presented an innovative and highly impactful scientific poster addressing the complex dual threats of weaponised Unmanned Aerial Systems (UAS) and illicit chemical dispersal. The topic was delivered at a prominent international emergency response and counter-terrorism symposium, highlighting the rapidly evolving landscape of asymmetric threats. Chetioui’s research focuses meticulously on an increasingly plausible intersection: the use of commercial drones to aerosolise and disperse highly potent synthetic opioids in densely populated spaces.
The poster was presented at the 7th International CBRNe Conference: Research and Innovation. The event took place in Arcachon, France and brought 680 experts representing 40 countries.
The core of the research detailed how synthetic opioids—such as fentanyl analogues—present an extreme hazard when weaponised via aerial dispersal. Because these substances are incredibly potent even in microgram quantities, an airborne or aerosolised release could incapacitate or cause fatal respiratory depression in hundreds of victims before first responders can accurately identify the agent.
The research underscored the core mission of Counter-Terrorism Medicine Europe: bridging the gap between field tactics, medical science, and operational intelligence.
